Sinoma Science & Technology Co.,Ltd.

SZSE:002080 Voorraadrapport

Marktkapitalisatie: CN¥21.8b

Sinoma Science & TechnologyLtd Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Sinoma Science & TechnologyLtd heeft een totaal eigen vermogen van CN¥26.4B en een totale schuld van CN¥17.1B, wat de schuld-eigenvermogensverhouding op 64.7% brengt. De totale activa en totale passiva bedragen respectievelijk CN¥58.4B en CN¥31.9B. De EBIT Sinoma Science & TechnologyLtd is CN¥1.2B waardoor de rentedekking 3.1 is. Het heeft contanten en kortetermijnbeleggingen van CN¥1.7B.

Belangrijke informatie

64.7%

Verhouding schuld/eigen vermogen

CN¥17.08b

Schuld

Rente dekkingsratio3.1x
ContantCN¥1.67b
AandelenCN¥26.42b
Totaal verplichtingenCN¥31.94b
Totaal activaCN¥58.36b

Recente financiële gezondheidsupdates

Recent updates

Sinoma Science & TechnologyLtd's (SZSE:002080) Problems Go Beyond Weak Profit

Nov 04
Sinoma Science & TechnologyLtd's (SZSE:002080) Problems Go Beyond Weak Profit

Even With A 44% Surge, Cautious Investors Are Not Rewarding Sinoma Science & Technology Co.,Ltd.'s (SZSE:002080) Performance Completely

Oct 08
Even With A 44% Surge, Cautious Investors Are Not Rewarding Sinoma Science & Technology Co.,Ltd.'s (SZSE:002080) Performance Completely

Should You Investigate Sinoma Science & Technology Co.,Ltd. (SZSE:002080) At CN¥9.99?

Sep 25
Should You Investigate Sinoma Science & Technology Co.,Ltd. (SZSE:002080) At CN¥9.99?

Estimating The Fair Value Of Sinoma Science & Technology Co.,Ltd. (SZSE:002080)

Sep 10
Estimating The Fair Value Of Sinoma Science & Technology Co.,Ltd. (SZSE:002080)

Bearish: Analysts Just Cut Their Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Revenue and EPS estimates

Aug 26
Bearish: Analysts Just Cut Their Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Revenue and EPS estimates

Sinoma Science & TechnologyLtd (SZSE:002080) Might Be Having Difficulty Using Its Capital Effectively

Aug 21
Sinoma Science & TechnologyLtd (SZSE:002080) Might Be Having Difficulty Using Its Capital Effectively

These 4 Measures Indicate That Sinoma Science & TechnologyLtd (SZSE:002080) Is Using Debt Extensively

Jul 25
These 4 Measures Indicate That Sinoma Science & TechnologyLtd (SZSE:002080) Is Using Debt Extensively

Why Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Could Be Worth Watching

Jun 10
Why Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Could Be Worth Watching

Sinoma Science & TechnologyLtd (SZSE:002080) Has Announced That Its Dividend Will Be Reduced To CN¥0.56

May 27
Sinoma Science & TechnologyLtd (SZSE:002080) Has Announced That Its Dividend Will Be Reduced To CN¥0.56

Capital Allocation Trends At Sinoma Science & TechnologyLtd (SZSE:002080) Aren't Ideal

May 13
Capital Allocation Trends At Sinoma Science & TechnologyLtd (SZSE:002080) Aren't Ideal

Are Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Investors Paying Above The Intrinsic Value?

Apr 14
Are Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Investors Paying Above The Intrinsic Value?

Earnings Troubles May Signal Larger Issues for Sinoma Science & TechnologyLtd (SZSE:002080) Shareholders

Mar 31
Earnings Troubles May Signal Larger Issues for Sinoma Science & TechnologyLtd (SZSE:002080) Shareholders

Sinoma Science & Technology Co.,Ltd.'s (SZSE:002080) Price Is Right But Growth Is Lacking

Mar 14
Sinoma Science & Technology Co.,Ltd.'s (SZSE:002080) Price Is Right But Growth Is Lacking

Should You Think About Buying Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Now?

Feb 28
Should You Think About Buying Sinoma Science & Technology Co.,Ltd. (SZSE:002080) Now?

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( CN¥19.7B ) 002080 } overtreffen de korte termijn passiva ( CN¥19.2B ).

Langlopende schulden: De kortetermijnactiva 002080 ( CN¥19.7B ) overtreffen de langetermijnschulden ( CN¥12.8B ).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 58.3% ) 002080 wordt als hoog beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van 002080 is de afgelopen 5 jaar gedaald van 68.1% naar 64.7%.

Schuldendekking: De schuld van 002080 wordt goed gedekt door de operationele kasstroom ( 37.7% ).

Rentedekking: De rentebetalingen op de schuld van 002080 worden goed gedekt door EBIT ( 3.1 x dekking).


Balans


Ontdek gezonde bedrijven